Catherine L. Coe, MD

Article

How do these 3 diabetes agents compare in reducing mortality?

Author:

Jennifer Martini, MD

Catherine L. Coe, MD

Anne Mounsey, MD

A meta-analysis reveals that there may be advantages associated with SGLT-2 inhibitors and GLP-1 agonists that are not associated with DPP-4...

• Read More